Case Studies

Craig I. Coleman, PharmD, and Andrew A. Perugini, PharmD Candidate
Published Online: Wednesday, February 15, 2012
Follow Pharmacy_Times:

Case One

CB is a 35-year-old man who comes to your pharmacy with a question concerning his migraine treatment. He states he experiences migraine headaches and has been treating them with sumatriptan 100 mg at the onset of migraine. In the past month he experienced 4 migraines, and the sumatriptan was not completely effective in treating the attack. He tells you that the last migraine he experienced was extremely painful and he had to call out of work. He is curious if there are any preventive treatment options that he can try. You notice in his profile that CB has hypertension but is not currently being treated for it. 

As his pharmacist, what advice would you give CB?


Case Two 

CO, a 27-year-old woman and new mother, comes to your pharmacy appearing very nervous. Her son is currently 1 month old, and she tells you that she has an appointment with his pediatrician in a month to receive his scheduled vaccinations. CO states she is worried about her son receiving vaccinations. She has heard that vaccinations contain mercury, which has been linked to autism. 

As her pharmacist, what advice should you give CO? 



Dr. Coleman is associate professor of pharmacy practice and director of the pharmacoeconomics and outcomes studies group at the University of Connecticut School of Pharmacy. Mr. Perugini is a PharmD candidate from the University of Connecticut School of Pharmacy. 

Related Articles
Exams, all-nighters, celebrations, vaccinations, rotations: these are just a few of the things students can expect in their journey from pharmacy student to pharmacist.
The FDA today approved sumatriptan and naproxen sodium to treat migraines in patients aged 12 to 17 years.
Research has shown that St. John’s wort could help patients suffering from depression.
Teva Pharmaceutical Industries’ investigational drug designed to prevent chronic migraines recently demonstrated positive results in a phase 2 study.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times